Novartis AG NVS
$152.43
+1.48%
at last close
Market Cap$285.49 billion
P/E Ratio—
Div Yield3.11%
Volume311.1K
52-Week Range
$121.57$170.46
Analyst Ratings
- Consensus
- Moderate Buy — 2 Buy · 3 Hold · 0 Sell (5 analysts)
- Avg. Price Target
- $153.00 (+0.4% upside)
Key Stats
- Today's Range
- $151.95 – $153.18
- 50-Day Range
- $137.00 – $164.48
- 52-Week Range
- $121.57 – $170.46
- Volume
- 311K shs
- Average Volume
- 1.89 million shs
- Market Cap
- $285.49 billion
- P/E Ratio
- —
- Dividend Yield
- 3.11%
Dividend
- Dividend Yield
- 3.11%
- Annual Dividend
- $4.74
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-03-11
Short Interest
- Short Interest
- 0.11%
- Days to Cover
- 2.53
About Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
Related Stocks
Compare head-to-head: NVS vs NVDA·NVS vs AAPL·NVS vs GOOG·NVS vs GOOGL
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.